Deal Library / Pharma BD Deal Intelligence

Boston Scientific Corporation — Pharma Deals

The Pharma Closeout tracks 4 deals, $7.1B in disclosed deal value, 3 with a post-close Outcome Score for Boston Scientific Corporation.

Median Critic Score: 84  ·  Median Outcome Score: 78

Best outcome: Boston Scientific Corporation / Endo International plc (American Medical Systems Men's Health and Prostate Health) (82)  ·  Weakest outcome: Boston Scientific Corporation / Advanced Bionics Corporation (26)

All 4 deals